This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
According to Berkley, over 70 nations have now signed up to the facility, including Japan, Norway and Germany, to procure vaccines through the COVAX facility for their respective nations.
health experts from a number of EU members states, Britain, Switzerland, Norway and the Balkans.
The German government’s Federal Ministry of Education and Research has already provided £157m to support CEPI’s development of a COVID-19 vaccine, joining the governments of Norway and the
The study showed that the UK performed worse than Australia, Canada, Denmark, Ireland, New Zealand and Norway in terms of cancer survival rates. .
The data will be presented at the European Academy of Neurology's (EAN) annual meeting in Oslo, Norway.
In March, Diurnal also signed its first partnership for Alkindi with Swedish group Anthrop Pharmaceuticals, which covers the commercialisation of the drug in Sweden, Norway, Denmark, Finland and Iceland, a
More from news
Approximately 1 fully matching, plus 127 partially matching documents found.
The Coalition for Epidemic Preparedness Innovations (CEPI), an Oslo, Norway-based nonprofit, is helping to coordinate the development of a COVID-19 vaccine and is leading the efforts to finance the
Notably the biosimilar Renflexis (infliximab-abda) achieved a 70-80% price reduction to its reference product in both Norway and Denmark.
As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing
More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
Was formerly general manager of Abbott in Norway. AbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business. ... Regan was formerly general manager for Abbott in Norway and will now oversee
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...